Department of Stomatology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, PR China.
Department of Stomatology, Longgang District Central Hospital, Chinese University of Hong Kong, Shenzhen, 518116, PR China.
J Cancer Res Clin Oncol. 2024 Aug 24;150(8):398. doi: 10.1007/s00432-024-05922-z.
Integrin β5 (ITGB5) is an integrin β subunit member widely expressed in the human bodies, especially in cancer cells and tissues, which is a key factor in promoting tumor metastasis. In this study we investigated the differential expression of ITGB5 in tongue squamous cell carcinoma (TSCC), especially in those with lymph node metastasis, and revealed the possible mechanism.
The expression of ITGB5 in TSCC was analyzed by database and verified by immunohistochemistry through 135 TSCC patients' tissue sections from Sun Yat-sen Memorial Hospital and Guangzhou First People's Hospital. The relationship between ITGB5 and lymph node metastasis or prognosis was analyzed retrospectively. The effects of ITGB5 on TSCC cells were examined through knocking down or overexpression and its possible regulator and signal pathway were explored.
The expression of ITGB5 in TSCC was higher than that in adjacent tissue, and the expression in patients with lymph node metastasis was higher than that in patients without lymph node metastasis. The high expression of ITGB5 predicted a worse prognosis. Knock down of ITGB5 suppressed invasion and migration of TSCC cells, while overexpression of ITGB5 contributed to invasion and migration. Reactive oxygen species (ROS) regulated epithelial mesenchymal transition (EMT), and we further verified that ROS enhanced the expression of ITGB5 to promote the metastasis of TSCC. Mechanistically, ITGB5 functions through cell adhesion signal pathway.
The increased expression of ITGB5 in tongue squamous cell carcinoma with lymph node metastasis may be a potential target for evaluating lymph node metastasis and worse prognosis of tongue squamous cell carcinoma. Scavenge of ROS or knock down of ITGB5 may be the strategies to overcome metastasis of TSCC.
整合素 β5(ITGB5)是一种广泛表达于人体的整合素β亚基成员,尤其在癌细胞和组织中表达,是促进肿瘤转移的关键因素。本研究旨在探讨 ITGB5 在舌鳞状细胞癌(TSCC)中的差异表达,特别是在有淋巴结转移的 TSCC 中的表达,并揭示其可能的机制。
通过数据库分析 ITGB5 在 TSCC 中的表达,并通过 135 例来自中山大学孙逸仙纪念医院和广州市第一人民医院的 TSCC 患者组织切片的免疫组化进行验证。回顾性分析 ITGB5 与淋巴结转移或预后的关系。通过敲低或过表达 ITGB5 研究其对 TSCC 细胞的影响,并探讨其可能的调节因子和信号通路。
ITGB5 在 TSCC 中的表达高于相邻组织,且有淋巴结转移的患者表达高于无淋巴结转移的患者。ITGB5 的高表达预示着预后较差。敲低 ITGB5 抑制了 TSCC 细胞的侵袭和迁移,而过表达 ITGB5 则促进了侵袭和迁移。活性氧(ROS)调节上皮间质转化(EMT),我们进一步证实,ROS 增强了 ITGB5 的表达,促进了 TSCC 的转移。从机制上讲,ITGB5 通过细胞黏附信号通路发挥作用。
在有淋巴结转移的舌鳞状细胞癌中 ITGB5 的表达增加,可能是评估淋巴结转移和舌鳞状细胞癌预后不良的潜在靶点。清除 ROS 或敲低 ITGB5 可能是克服 TSCC 转移的策略。